Cargando…

RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene

The expression and function of some xenobiotic transporters vary according to the time of the day, causing the dosing time-dependent changes in drug disposition and toxicity. P-glycoprotein (P-gp), encoded by the ABCB1 gene, is highly expressed in the kidneys and functions in the renal elimination o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omata, Yuji, Yamauchi, Tomoaki, Tsuruta, Akito, Matsunaga, Naoya, Koyanagi, Satoru, Ohdo, Shigehiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095175/ https://www.ncbi.nlm.nih.gov/pubmed/33781748 http://dx.doi.org/10.1016/j.jbc.2021.100601

Ejemplares similares

RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells
por: Omata, Yuji, et al.
Publicado: (2022)

Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
por: Tsuruta, Akito, et al.
Publicado: (2022)

Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells
por: Ogino, Takashi, et al.
Publicado: (2021)

Dysfunction of the circadian transcriptional factor CLOCK in mice resists chemical carcinogen-induced tumorigenesis
por: Hashikawa, Ken-ichi, et al.
Publicado: (2017)

Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis
por: Yoshida, Yuya, et al.
Publicado: (2021)

Circadian clock component PERIOD2 regulates diurnal expression of Na(+)/H(+) exchanger regulatory factor-1 and its scaffolding function
por: Tsurudome, Yuya, et al.
Publicado: (2018)

Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain
por: Kusunose, Naoki, et al.
Publicado: (2010)

Diurnal expression of MRP4 in bone marrow cells underlies the dosing-time dependent changes in the oxaliplatin-induced myelotoxicity
por: Kato, Mizuki, et al.
Publicado: (2020)

The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023)

The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S
por: Hayashi, Yoshinori, et al.
Publicado: (2013)

Dissecting the splicing mechanism of the Drosophila editing enzyme; dADAR
por: Marcucci, Roberto, et al.
Publicado: (2009)

RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing
por: Xing, Yanfang, et al.
Publicado: (2023)

Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity
por: Singh, Kuljeet, et al.
Publicado: (2021)

Inhibition of G0/G1 Switch 2 Ameliorates Renal Inflammation in Chronic Kidney Disease
por: Matsunaga, Naoya, et al.
Publicado: (2016)

ADAR1 Editing and its Role in Cancer
por: Xu, Li-Di, et al.
Publicado: (2018)

Expression of concern on ‘Dissecting the splicing mechanism of the Drosophila editing enzyme; dADAR’
Publicado: (2023)

Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia
por: Koyanagi, Satoru, et al.
Publicado: (2016)

RNA Editing, ADAR1, and the Innate Immune Response
por: Wang, Qingde, et al.
Publicado: (2017)

P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease
por: Sita, Giulia, et al.
Publicado: (2017)

Structure of ABCB1/P-Glycoprotein in the Presence of the CFTR Potentiator Ivacaftor
por: Barbieri, Alessandro, et al.
Publicado: (2021)

Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects
por: Keegan, Liam P., et al.
Publicado: (2011)

A-to-I RNA editing enzyme ADAR2 regulates light-induced circadian phase-shift
por: Terajima, Hideki, et al.
Publicado: (2018)

Modulation of ADAR1 editing activity by Z-RNA in vitro
por: Koeris, Michael, et al.
Publicado: (2005)

ADAR1-Mediated RNA Editing and Its Role in Cancer
por: Liu, Jizhe, et al.
Publicado: (2022)

ADAR-deficiency perturbs the global splicing landscape in mouse tissues
por: Kapoor, Utkarsh, et al.
Publicado: (2020)

Functional Impact of ABCB1 Variants on Interactions between P-Glycoprotein and Methadone
por: Hung, Chin-Chuan, et al.
Publicado: (2013)

Investigation of the effects of the CFTR potentiator ivacaftor on human P-glycoprotein (ABCB1)
por: Lingam, Swathi, et al.
Publicado: (2017)

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
por: Maia, Raquel C., et al.
Publicado: (2018)

Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods
por: Mora Lagares, Liadys, et al.
Publicado: (2022)

Ozagrel hydrochloride, a selective thromboxane A(2) synthase inhibitor, alleviates liver injury induced by acetaminophen overdose in mice
por: Tomishima, Yoshiro, et al.
Publicado: (2013)

Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing
por: Wei, Jun, et al.
Publicado: (2014)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

ADAR RNA editing below the backbone
por: Keegan, Liam, et al.
Publicado: (2017)

Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases
por: Song, Chunzi, et al.
Publicado: (2016)

ADAR1-mediated RNA-editing of 3′UTRs in breast cancer
por: Sagredo, Eduardo A., et al.
Publicado: (2018)

RNA editing enzyme ADAR1 is required for early T cell development
Publicado: (2022)

RNA editing enzyme ADAR1 is required for early T cell development
por: Xufeng, Richard, et al.
Publicado: (2020)

The RNA editing enzyme ADAR2 restricts L1 mobility
por: Frassinelli, Loredana, et al.
Publicado: (2021)

ADAR1-mediated RNA editing promotes B cell lymphomagenesis
por: Pecori, Riccardo, et al.
Publicado: (2023)

Applying Human ADAR1p110 and ADAR1p150 for Site-Directed RNA Editing—G/C Substitution Stabilizes GuideRNAs against Editing
por: Heep, Madeleine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ncjjaimordpi68lafhmgo7f86a